CLASS ACTION UPDATE for ABBV, IBM and MYPS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
AbbVie, Inc. Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Important Lead Plaintiff Deadline on June 6, 2022 in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
CLASS ACTION UPDATE for FB, CELH and AUPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
AUPH NOTICE: ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
IBM, ABBV, & TWTR Class Actions: Bronstein, Gewirtz & Grossman, LLC, A Top Class Action Firm Reminds Shareholders to Actively Participate Pharmaceutical Investing
ROSEN, A LEADING LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
SHAREHOLDER ALERT: ABBV MYPS AUPH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
Attention Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed Against AbbVie, Inc. and Encourages Investors to Contact the Firm Pharmaceutical Investing
Notice of New Dial-In Numbers for Aurinia Pharmaceuticals First Quarter 2022 Financial and Operational Results on May 10, 2022 Pharmaceutical Investing
Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of AbbVie, Inc. of Securities Class Action Lawsuit and Urges Investors with Significant Losses to Contact the Firm Pharmaceutical Investing
